Cardiology (all articles)
Review, Statements, and Recommendations: Cuffless blood pressure measuring devices.
20 Jun, 2022 | 01:26h | UTCRelated:
Perspective | Cardiovascular meta-analyses: fool’s gold or gold for fools?
20 Jun, 2022 | 01:15h | UTCCardiovascular meta-analyses: fool’s gold or gold for fools? – European Heart Journal
Prospective head-to-head comparative study: Functional stress imaging to predict abnormal coronary fractional flow reserve.
20 Jun, 2022 | 01:10h | UTC
Commentary on Twitter
Functional stress imaging to predict abnormal coronary fractional flow reserve: new insights from the PACIFIC 2 study!https://t.co/5N0dOW2Rem#PET #MRI #FFR #CCS #coronary #cardiotwitter @escardio @ESC_Journals pic.twitter.com/WCoA0cOgd9
— EHJ Editor-in-Chief (@ehj_ed) June 17, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Cardiac xenotransplantation: challenges, evolution, and advances.
20 Jun, 2022 | 00:58h | UTCCommentary: Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off – TCTMD
Related:
In 1st, US surgeons transplant pig heart into human patient – Associated Press
Results of Two Cases of Pig-to-Human Kidney Xenotransplantation – New England Journal of Medicine (link to abstract – $ for full-text)
After a flurry of firsts, xenotransplantation is suddenly back in the spotlight – STAT
M-A: Heat exposure and cardiovascular health outcomes.
20 Jun, 2022 | 01:00h | UTC
Commentary on Twitter (thread – click for more)
New review out in @TheLancetPlanet on #heat from #climatechange and #cardiovascular #publichealth. Shows 1deg Celsius increases cardio mortality by 2.1%. https://t.co/RLsGU8dIS7
— Nicole Iroz Elardo (@NIrozElardo) June 14, 2022
AHA Scientific Statement: Revascularization for renovascular disease.
17 Jun, 2022 | 11:50h | UTCTop Things to Know: Revascularization for Renovascular Disease – American Heart Association
Commentary: When is Renovascular Hypertension Amenable to Revascularization – American Heart Association
Cohort Study: Association of sitting time with mortality and cardiovascular events in high-income, middle-income, and low-income countries.
17 Jun, 2022 | 11:05h | UTCAssociation of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries – JAMA Cardiology (free for a limited period)
Commentary: Trade the chair for fresh air: Sitting time and cardio health – Simon Fraser University
Commentary from one of the authors on Twitter
Our study in 105K people from #PURE study:
🌟⬆️ sitting associated with >early death & heart disease
🌟association > in low income countries
🌟being active can counteract risk
🌟every 30 min of sitting replaced by #exercise, risk⬇️ 2%#healthy@JAMACardio: https://t.co/rR61SolkXs pic.twitter.com/ESUFXy6Pvj— Scott Lear, PhD (@DrScottLear) June 15, 2022
Post Hoc Secondary Analysis of RCT: Rivaroxaban monotherapy is associated with better outcomes vs. combination therapy with antiplatelets in patients with atrial fibrillation and stable coronary artery disease.
17 Jun, 2022 | 11:07h | UTCRivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial – JAMA Cardiology (free for a limited period)
Commentaries:
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More? – JAMA Cardiology (free for a limited period)
Rivaroxaban Monotherapy Linked to Lower Event Risk in Patients with AF, Stable CAD – HCPLive
Commentary on Twitter
In this post-hoc study of the AFIRE RCT, recurrent event analyses showed that rivaroxaban monotherapy was associated with lower risks of total thrombotic and/or bleeding events than rivaroxaban plus antiplatelet therapy in patients with AF and stable CAD. https://t.co/TGwatvlrKR
— JAMA Cardiology (@JAMACardio) June 15, 2022
Inappropriate sinus tachycardia: etiology, pathophysiology, and management.
16 Jun, 2022 | 11:05h | UTC
M-A: Acute or subacute, the optimal timing for uncomplicated Type B aortic dissection.
16 Jun, 2022 | 10:46h | UTC
RCT: Effect of legumes in energy reduced dietary approaches to stop hypertension (DASH) diet on blood pressure among overweight and obese type 2 diabetic patients.
16 Jun, 2022 | 10:41h | UTC
M-A: Transcatheter aortic valve implantation with and without resheathing and repositioning.
15 Jun, 2022 | 10:55h | UTC
Cross Sectional Study: Underdiagnosis and undertreatment of modifiable cardiovascular risk factors among survivors of childhood cancer.
15 Jun, 2022 | 10:43h | UTCCommentaries:
Survivors of Childhood Cancer More Likely to Be Undertreated for CVD Risk Factors – AMJC
Cohort Study | Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration.
15 Jun, 2022 | 10:34h | UTC
State of the Art Review: Revascularization in stable coronary artery disease.
14 Jun, 2022 | 11:15h | UTCRevascularization in stable coronary artery disease – The BMJ
Analysis of age, sex, lack of response to intravenous immunoglobulin, and development of coronary artery abnormalities in a large cohort of children with Kawasaki disease in Japan.
14 Jun, 2022 | 10:54h | UTC
Isolated coarctation of the aorta: current concepts and perspectives.
14 Jun, 2022 | 10:49h | UTC
RCT: Emergency vs. delayed coronary angiogram in survivors of out-of-hospital cardiac arrest.
13 Jun, 2022 | 10:42h | UTCEmergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac Arrest: Results of the Randomized, Multicentric EMERGE Trial – JAMA Cardiology (free for a limited period)
Commentary on Twitter
In this RCT, performing an emergency coronary angiogram (CAG) after an out-of-hospital cardiac arrest without ST-segment elevation showed no difference in the 180-day survival rate compared to a delayed CAG. https://t.co/gYwPdNV32v
— JAMA Cardiology (@JAMACardio) June 8, 2022
Guidelines for the management of hypertension.
13 Jun, 2022 | 08:13h | UTC
Subgroup analyses in randomized clinical trials: value and limitations.
13 Jun, 2022 | 07:57h | UTC
Expert Analysis: Pericarditis management in pregnancy.
13 Jun, 2022 | 07:49h | UTCPericarditis Management in Pregnancy – American College of Cardiology
SGLT2 inhibitor reduces the risk of hyperkalemia in patients with heart failure.
13 Jun, 2022 | 07:52h | UTCEditorial: Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure
Commentary on Twitter
More evidence that SGLT2i ⬇️ hyperK, this time in heart failure
Empagliflozin reduces:
– K>6.0: HR 0.62 95% CI 0.48–0.81
– Investigator reported hyperK or K binders, HR 0.82 95% CI 0.71-0.95
– Effect modified by GFR – larger in CKD
– Regardless of MRAshttps://t.co/t4T7II1G8p pic.twitter.com/RP1EUKXHyV— Brendon Neuen (@brendonneuen) June 12, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Retrospective Cohort Study: Incidence of major adverse cardiac events with immune checkpoint inhibitors.
13 Jun, 2022 | 07:32h | UTCRelated:
Cardiotoxicity of immune checkpoint inhibitors – ESMO Open
Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature
Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: A population-based and sibling-controlled cohort study.
10 Jun, 2022 | 11:12h | UTCRelated:
Mental Stress and Its Effects on Vascular Health – Mayo Clinic Proceedings
Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine
Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine
Cardiovascular Events during World Cup Soccer – New England Journal of Medicine
Antiplatelet therapy in atherothrombotic diseases: similarities and differences across guidelines.
10 Jun, 2022 | 10:44h | UTC